Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii.
about
Recombinant vaccines against T. gondii: comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1Recombinant TgHSP70 Immunization Protects against Toxoplasma gondii Brain Cyst Formation by Enhancing Inducible Nitric Oxide Expression.Sarcocystis neurona merozoites express a family of immunogenic surface antigens that are orthologues of the Toxoplasma gondii surface antigens (SAGs) and SAG-related sequences.Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosisThe LTR72 mutant of heat-labile enterotoxin of Escherichia coli enhances the ability of peptide antigens to elicit CD4(+) T cells and secrete gamma interferon after coapplication onto bare skinMyD88-dependent protective immunity elicited by adenovirus 5 expressing the surface antigen 1 from Toxoplasma gondii is mediated by CD8(+) T lymphocytes.Challenge model for Helicobacter pylori infection in human volunteers.Vaccination with Toxoplasma gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB/c mice but not in CBA/J mice.Vaccination concepts against Toxoplasma gondii.Vaccines against Toxoplasma gondii: challenges and opportunities.Antigen replacement of domains D2 and D3 in flagellin promotes mucosal IgA production and attenuates flagellin-induced inflammatory response after intranasal immunization.Possible link between Toxoplasma gondii and the anosmia associated with neurodegenerative diseases.Recent advances in Toxoplasma gondii immunotherapeutics.rROP2 from Toxoplasma gondii as a potential vaccine against oocyst shedding in domestic cats.Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice.Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route.Recombinant ROP2, ROP4, GRA4 and SAG1 antigen-cocktails as possible tools for immunoprophylaxis of toxoplasmosis: what's next?Intraperitoneal and intra-nasal vaccination of mice with three distinct recombinant Neospora caninum antigens results in differential effects with regard to protection against experimental challenge with Neospora caninum tachyzoites.Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii.Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis.Toxoplasma gondii: humoral and cellular immune response of BALB/c mice immunized via intranasal route with rTgROP2.Analysis of the immune response to Neospora caninum in a model of intragastric infection in mice
P2860
Q27321063-D3A6023E-F45C-4259-9398-A878836CFB5BQ33599823-46827D46-F341-4CA4-9621-7B0079745B18Q33792570-743489E2-539D-445E-8607-DACF2C437EC4Q34122078-547EA16C-4297-479E-93C1-B7E3AB73BD12Q34123358-632EDFE8-5FEE-48A5-BF8B-5139BE14C2ADQ35046630-D909C78D-A6C4-4819-8C0F-C2C81E027485Q35596803-FB18BDEA-3911-45F4-8BBD-6C1361A67780Q36375429-87BDCF4A-5ECD-4050-B660-7490EA0FAA19Q37386300-357B27B3-4EA5-4959-B636-3369155DFD69Q37476759-46EEC9F8-5AD4-4FC4-A8B9-800131A82E12Q37505389-132993AE-7680-4B82-A352-14BEE60A33C6Q38177635-B24CEC59-36AC-4DAF-BCB5-F0D2B83202A1Q38303517-4E3FE277-086E-4E1E-BC6D-8616C7DBC1A4Q38731230-D719B029-950F-494D-B390-FD4592BBF47CQ39654314-171E694D-02EC-48D2-A5AA-FF67ADB350A4Q40498945-3503BF5F-2DA8-4DD1-A8B2-EDC5C7EF4DE8Q41476002-0F03B501-3640-40D8-8E6E-73A65FC4E1E9Q43704579-85166B2F-EAED-4D24-A039-CF240FEDCA5FQ51358760-ACEF6BF2-5A38-49AE-9503-06AB737AAD5BQ51743228-7D27DE9A-30D4-433D-A355-7EEA8BAFA51BQ54373467-92888F97-1BD1-4D00-A8F3-3704E8E7A3DBQ57589936-91D84C8A-0C35-43DD-9ADD-FC8871D71428
P2860
Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Intranasal immunization with S ...... ice against Toxoplasma gondii.
@ast
Intranasal immunization with S ...... ice against Toxoplasma gondii.
@en
Intranasal immunization with S ...... ice against Toxoplasma gondii.
@nl
type
label
Intranasal immunization with S ...... ice against Toxoplasma gondii.
@ast
Intranasal immunization with S ...... ice against Toxoplasma gondii.
@en
Intranasal immunization with S ...... ice against Toxoplasma gondii.
@nl
prefLabel
Intranasal immunization with S ...... ice against Toxoplasma gondii.
@ast
Intranasal immunization with S ...... ice against Toxoplasma gondii.
@en
Intranasal immunization with S ...... ice against Toxoplasma gondii.
@nl
P2093
P2860
P1476
Intranasal immunization with S ...... ice against Toxoplasma gondii.
@en
P2093
Bonenfant C
Buzoni-Gatel D
Del Giudice G
Dimier-Poisson I
Velge-Roussel F
P2860
P304
P356
10.1128/IAI.69.3.1605-1612.2001
P407
P577
2001-03-01T00:00:00Z